Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
International dementia sits at the center of this dementia and brain health question.
Recent global research efforts have shifted the conversation around dementia from inevitability to prevention. While a specific consortium bearing the exact name “The International Dementia Prevention Research Consortium” could not be independently verified, the dementia prevention research landscape includes major multi-country analyses that provide meaningful insights. The 2024 Lancet Commission Report represents one of the most comprehensive international efforts, identifying 14 modifiable risk factors that account for approximately 45% of global dementia cases. This finding alone represents a fundamental shift in how we understand dementia—suggesting that nearly half of all cases worldwide could potentially be prevented through lifestyle and environmental interventions.
The international research on dementia prevention extends across numerous countries and health systems. A 2025 analysis examined National Dementia Plans from 16 European and North American countries to understand how different regions are approaching prevention, revealing significant variations in strategy and resource allocation. Additionally, studies like “The Exposome of Healthy and Accelerated Aging Across 40 Countries” have examined environmental and lifestyle factors across diverse populations, providing comparative data on aging patterns globally. These efforts collectively demonstrate that dementia prevention is no longer viewed as a single-country challenge but as a global priority requiring coordinated research and policy responses.
Table of Contents
- What Do Global Dementia Prevention Studies Actually Reveal About Modifiable Risk Factors?
- The Challenge of Comparing Prevention Strategies Across 40+ Countries
- Which Modifiable Risk Factors Have the Strongest Evidence for Prevention?
- How Can Individuals and Healthcare Systems Apply This Research to Prevention?
- What Are the Major Limitations and Gaps in Global Dementia Prevention Research?
- How Do Cardiovascular and Metabolic Health Connect to Dementia Prevention Globally?
- The Future of International Dementia Prevention Research and Policy
- Conclusion
- Frequently Asked Questions
What Do Global Dementia Prevention Studies Actually Reveal About Modifiable Risk Factors?
The 2024 Lancet Commission Report fundamentally changed the evidence base for dementia prevention by identifying 14 specific modifiable risk factors. These factors include well-known elements like cognitive engagement, physical activity, and hearing correction, but the commission also added newer findings including visual impairment and hypercholesterolemia to the list. The significance of this expanded list lies not in its novelty but in its quantifiable impact: together, these 14 factors account for nearly 45% of dementia cases globally. This means that for roughly 30 million of the estimated 67 million people living with dementia worldwide, the disease may have been preventable through modifications to diet, lifestyle, or medical management. What makes the international research particularly valuable is the comparison across different healthcare systems and cultural contexts.
When researchers examined National Dementia Plans from European and North American countries in 2025, they discovered that prevention approaches vary dramatically. Some countries emphasize early screening and cognitive training, while others prioritize cardiovascular health and physical activity promotion. For example, one country’s national plan might focus heavily on hearing aid access and cognitive stimulation, while another prioritizes hypertension management and diabetes prevention. These differences suggest that while the underlying science is consistent, implementation strategies must be adapted to local healthcare infrastructure and population characteristics. The limitation here is significant: data from wealthier nations may not translate directly to lower-income countries where healthcare access, diet, and lifestyle options are fundamentally different.
The Challenge of Comparing Prevention Strategies Across 40+ Countries
Comparing dementia prevention approaches across multiple countries reveals both the promise and the practical limitations of global health research. Studies examining aging and health outcomes across 40 countries face methodological challenges that can obscure real differences. researchers must account for variations in how dementia is diagnosed, differences in life expectancy (a country where fewer people reach age 80 will naturally have lower dementia rates), and disparities in healthcare quality and access. A country with excellent early detection systems will report higher dementia prevalence than one where cases go undiagnosed until late stages, making direct comparisons misleading. The economic disparity across countries compounds these measurement challenges.
In high-income nations, hearing aids, cognitive training programs, and cardiovascular medications are relatively accessible, making these modifiable risk factors manageable for many people. In lower and middle-income countries, these interventions may be unavailable or unaffordable for the majority of the population. A study comparing prevention success across 40 countries must therefore acknowledge a critical limitation: apparent differences in dementia rates may reflect differences in healthcare access rather than differences in the actual burden of disease. When the 2024 Lancet Commission identified 14 modifiable risk factors, it provided a roadmap, but the ability of different countries to implement interventions varies enormously. A recommendation to treat hypercholesterolemia is most useful in countries where statins are readily available and affordable.
Which Modifiable Risk Factors Have the Strongest Evidence for Prevention?
Among the 14 identified modifiable risk factors, research shows that certain interventions have particularly robust evidence. Cognitive engagement—meaning activities that challenge the brain such as learning new skills, reading, or social interaction—consistently shows protective effects in multiple countries and populations. Similarly, physical activity emerges as preventive across diverse healthcare contexts; the mechanism appears to involve cardiovascular benefits, neuroplasticity, and reduced inflammation. Hearing correction stands out as particularly significant because untreated hearing loss is both modifiable and highly prevalent in aging populations. Studies show that hearing aid use is associated with better cognitive outcomes, yet many older adults do not pursue treatment due to stigma, cost, or difficulty with devices.
The newer additions to the dementia risk factor list—visual impairment and hypercholesterolemia—represent an evolving understanding of dementia’s causes. Visual impairment may contribute to dementia risk through multiple pathways: reduced social engagement due to vision loss, increased falls and head injury risk, or shared vascular pathology underlying both visual and cognitive decline. When researchers analyzed National Dementia Plans across 16 countries, they found that eye health screening and correction were often overlooked compared to cardiovascular risk management. This gap represents a practical example of how global research can identify prevention opportunities that individual healthcare systems may not yet prioritize. For instance, a comprehensive eye care program targeting older adults might prevent cognitive decline more cost-effectively than some other interventions, yet such programs exist in only a fraction of countries studied.
How Can Individuals and Healthcare Systems Apply This Research to Prevention?
For individuals, the international research on dementia prevention suggests a multi-pronged approach rather than reliance on any single intervention. A 65-year-old person seeking to reduce dementia risk should consider addressing multiple factors simultaneously: maintaining cardiovascular health through blood pressure and cholesterol management, engaging in regular physical activity, staying cognitively active through learning and social engagement, correcting hearing and vision problems, managing diabetes and obesity, limiting alcohol, avoiding smoking, and maintaining quality sleep. The advantage of this approach is that many interventions benefit overall health beyond dementia prevention. However, the limitation is practical: simultaneously addressing 14 risk factors requires sustained effort and often professional support.
Healthcare systems face a different challenge: how to implement prevention at a population level with limited resources. The analysis of National Dementia Plans from European and North American countries revealed that well-resourced systems tend to emphasize early detection and specialized intervention programs, while less-resourced systems focus on public education and primary prevention through simpler, lower-cost approaches. A practical comparison: a high-income country might establish specialist memory clinics to identify cognitive decline early, while another country might prioritize public awareness campaigns about hearing aid access, stroke prevention, and exercise. Neither approach is necessarily superior; the choice depends on healthcare capacity and population needs. The tradeoff is between precision (early identification of those at risk) and reach (influencing prevention behaviors across entire populations).
What Are the Major Limitations and Gaps in Global Dementia Prevention Research?
The international dementia prevention research landscape, while advancing rapidly, contains significant gaps that limit its immediate applicability. First, most research on dementia prevention comes from high-income countries with predominantly older populations of European descent. When studies examine aging and health outcomes across 40 countries, underrepresented populations include people in sub-Saharan Africa, South Asia, and Central America where dementia burden is rising rapidly but research capacity is limited. This matters because risk factors may operate differently in different genetic backgrounds and cultural contexts. For example, the protective effect of cognitive engagement might be modified by educational access, which varies dramatically across countries.
A warning worth emphasizing: preventing dementia in high-income countries may require different strategies than in countries where infectious diseases, malnutrition, and untreated hypertension are more prevalent. Second, most dementia prevention research focuses on prevention in people who have not yet developed cognitive symptoms. Research on slowing progression in those who have already experienced cognitive decline remains limited, and preventing dementia in the very oldest (age 85+) has received less attention than prevention in younger old adults. The 2024 Lancet Commission identified 14 modifiable risk factors, but the strength of evidence varies: some factors are supported by strong randomized trials while others rest on observational studies prone to confounding. A final limitation specific to international comparisons: the countries included in large studies often represent a narrow band of global economic development. The National Dementia Plans analyzed in 2025 came primarily from Europe and North America, leaving questions about how dementia prevention is being approached in Asia, Africa, Latin America, and Oceania.
How Do Cardiovascular and Metabolic Health Connect to Dementia Prevention Globally?
The identification of hypercholesterolemia as a modifiable dementia risk factor highlights a critical insight: vascular health and cognitive health are inseparable. The same processes that damage blood vessels and cause heart disease can damage the small vessels that nourish the brain, leading to vascular cognitive impairment and dementia. International research shows that people with high cholesterol, high blood pressure, diabetes, and obesity face elevated dementia risk beyond what would be explained by age alone.
A practical example: a 70-year-old with well-controlled blood pressure and cholesterol and normal weight has a substantially lower dementia risk than an age-matched peer with hypertension, elevated cholesterol, and obesity, even if other lifestyle factors are similar. Yet here emerges a practical challenge revealed in global research: the medications and monitoring systems needed to manage cardiovascular risk factors are not equally distributed. Statin therapy for cholesterol, antihypertensive medications, and glucose monitoring for diabetes prevention require healthcare infrastructure, consistent medication access, and medical follow-up that exists reliably in high-income countries but sporadically elsewhere. When the 2024 Lancet Commission identified hypercholesterolemia as a modifiable dementia risk factor, this represented important scientific progress, but the ability to modify this factor globally depends on healthcare system strength and pharmaceutical access.
The Future of International Dementia Prevention Research and Policy
The trajectory of international dementia prevention research is shifting toward larger, more inclusive studies and toward implementation research that tests whether the identified risk factors can actually be modified in real-world settings. Future research efforts will likely include more countries, more diverse populations, and more attention to how prevention strategies can be adapted to different economic and healthcare contexts. One emerging priority is understanding dementia prevention in low and middle-income countries where dementia incidence is projected to rise dramatically over the next decades. Research comparing aging outcomes across 40 countries provides a foundation, but we need targeted studies in regions where dementia burden will be concentrated in 2030 and beyond.
The policy implications of international dementia prevention research are just beginning to materialize. Countries that have examined their National Dementia Plans alongside international evidence are increasingly shifting resources from treatment toward prevention and early detection. However, the degree to which countries can implement evidence-based prevention depends fundamentally on healthcare funding, political will, and integration of dementia prevention into broader health systems addressing cardiovascular disease, diabetes, and aging. The next decade will likely determine whether the 14 modifiable risk factors identified in recent research translate into actual dementia prevention at scale globally or remain primarily accessible to populations in well-resourced healthcare systems.
Conclusion
Recent international research on dementia prevention has identified 14 modifiable risk factors that account for approximately 45% of global dementia cases. This represents a significant shift in how the field understands dementia—from a disease that is inevitable with age to one that is substantially preventable through lifestyle, behavioral, and medical interventions. Research comparing aging and health outcomes across multiple countries, along with analyses of how different nations are implementing prevention strategies, reveals both the promise of a prevention-focused approach and the practical challenges of implementing it globally.
The path forward requires sustained international research that includes more diverse populations, continued investigation of how risk factors operate in different cultural and economic contexts, and commitment to translating research findings into accessible prevention programs. For individuals concerned about dementia risk, the evidence suggests addressing multiple modifiable factors simultaneously rather than relying on any single intervention. For healthcare systems and policymakers, the evidence indicates that dementia prevention must be integrated into broader efforts to manage cardiovascular disease, metabolic health, cognitive engagement, and sensory function across the lifespan.
Frequently Asked Questions
What are the 14 modifiable dementia risk factors identified by recent research?
The 2024 Lancet Commission identified cognitive engagement, physical activity, hearing correction, hypertension management, diabetes control, obesity management, smoking cessation, alcohol limitation, sleep quality, social engagement, air pollution reduction, depression management, visual impairment correction, and hypercholesterolemia management as modifiable factors. These 14 factors together account for approximately 45% of global dementia cases.
How do the modifiable risk factors differ across countries?
Healthcare systems, cultural practices, economic resources, and healthcare infrastructure vary dramatically. Countries differ in which risk factors they prioritize for prevention (some emphasize cognitive training while others focus on cardiovascular management) and in their ability to implement interventions. A high-income country with excellent hearing aid access may successfully implement hearing correction as dementia prevention, while a lower-income country may need different strategies.
Can dementia be completely prevented by modifying these risk factors?
No. The 14 modifiable risk factors account for approximately 45% of dementia cases, meaning 55% of dementia cases involve genetic, unexplained, or non-modifiable factors. Even optimal management of all 14 modifiable factors cannot guarantee dementia prevention, though it substantially reduces risk for many individuals.
Why is international research on dementia prevention important?
International research reveals how dementia prevention strategies work in different populations, healthcare systems, and economic contexts. It identifies gaps in current prevention efforts, tests whether strategies effective in one setting work in others, and provides evidence for developing culturally and economically appropriate prevention programs globally.
What is the role of cardiovascular health in dementia prevention?
Cardiovascular risk factors including hypertension, high cholesterol, diabetes, and obesity contribute to dementia through vascular damage that reduces blood flow to the brain. The mechanisms overlap substantially with vascular disease, meaning prevention strategies for heart disease and stroke simultaneously reduce dementia risk.
Should older adults focus on preventing dementia or treating cognitive decline that has already begun?
The evidence is stronger for preventing dementia in cognitively normal older adults than for slowing progression in those with existing cognitive impairment. However, the same modifiable risk factors (cardiovascular health, cognitive engagement, physical activity) are likely beneficial even after cognitive decline begins. A 75-year-old with mild cognitive impairment should not abandon attention to these factors, though the potential benefit may be more limited than for prevention in cognitively normal individuals.
You Might Also Like
- The Government Funded Dementia Research Center Network That Spans 33 Sites Across the Country
- How One Study Found That People Who Maintain Purpose in Life After Retirement Have 30% Lower Dementia Risk
- The Global Brain Health Institute Training Program That Has Graduated 800 Dementia Prevention Leaders
For more, see Alzheimer’s Association — clinical trials.
